Temporal Trends in Quality of Life Outcomes after Transapical TAVR: A PARTNER Trial Substudy

BACKGROUND: In the PARTNER randomized controlled trial (RCT), which represented the first exposure to transapical transcatheter aortic valve replacement (TA-TAVR) for many clinical sites, high risk patients undergoing TA-TAVR derived similar health-related quality-of-life (HRQoL) outcomes when compa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Circ Cardiovasc Qual Outcomes
Hlavní autoři: Gada, Hemal, Kirtane, Ajay J, Wang, Kaijun, Lei, Yang, Magnuson, Elizabeth, Reynolds, Matthew R, Williams, Mathew R, Kodali, Susheel, Vahl, Torsten P, Arnold, Suzanne V, Leon, Martin B, Thourani, Vinod, Szeto, Wilson Y, Cohen, David J
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4786368/
https://ncbi.nlm.nih.gov/pubmed/26058718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.114.001335
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky